Search Results - "Selva‐O'Callaghan, Albert"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies by Scirè, Carlo Alberto, Gonzalez-Gay, Miguel A, Selva-O’Callaghan, Albert, Cavagna, Lorenzo

    Published in Respiratory medicine (01-11-2017)
    “…Highlights • Classification criteria for antisyntehase syndrome (ASSD) are lacking. • Lung involvement is common in antisynthetase Ab (anti-ARS) positive…”
    Get full text
    Journal Article
  7. 7

    Effectiveness of a psychoeducational intervention on myositis patients’ quality of life and well-being: a randomized controlled trial by Armadans-Tremolosa, Imma, Palacin-Lois, Maria, Castrechini-Trotta, Angela, Sanduvete-Chaves, Susana, Chacón-Moscoso, Salvador, Selva-O'Callaghan, Albert

    Published in Orphanet journal of rare diseases (01-11-2024)
    “…Abstract Background Myositis is a rare disease associated with impaired health-related quality of life. A study evaluating the effectiveness of an intervention…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Malignancy and myositis: novel autoantibodies and new insights by Selva-OʼCallaghan, Albert, Trallero-Araguás, Ernesto, Grau-Junyent, Josep M, Labrador-Horrillo, Moisés

    Published in Current opinion in rheumatology (01-11-2010)
    “…PURPOSE OF REVIEWCurrently available data support the idea that inflammatory myopathies, particularly dermatomyositis, are paraneoplastic diseases. Cancer…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Gastrointestinal Involvement in Dermatomyositis by Matas-Garcia, Ana, Milisenda, José C, Espinosa, Gerard, Cuatrecasas, Míriam, Selva-O'Callaghan, Albert, Grau, Josep María, Prieto-González, Sergio

    Published in Diagnostics (Basel) (11-05-2022)
    “…Dermatomyositis is a systemic vasculopathy mainly affecting skin, muscle and lung, but may affect the gastrointestinal tract. We aim to describe clinical…”
    Get full text
    Journal Article
  15. 15

    Opportunistic infections in patients with idiopathic inflammatory myopathies by Redondo‐Benito, Ada, Curran, Adrian, Villar‐Gomez, Ana, Trallero‐Araguas, Ernesto, Fernández‐Codina, Andreu, Pinal‐Fernandez, Iago, Rodrigo‐Pendás, Jose Ángel, SelvaO'Callaghan, Albert

    “…Aim To describe the prevalence, clinical characteristics and risk factors of opportunistic infection (OI) in a cohort of patients with inflammatory myopathies,…”
    Get full text
    Journal Article
  16. 16

    Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies by Mahler, Michael, Malyavantham, Kishore, Seaman, Andrea, Bentow, Chelsea, Anunciacion-Llunell, Ariadna, Sanz-Martínez, María Teresa, Viñas-Gimenez, Laura, Selva-O'Callaghan, Albert

    Published in Diagnostics (Basel) (30-11-2021)
    “…(1) Background: Myositis specific antibodies (MSA) represent important diagnostic and stratification tools in idiopathic inflammatory myositis (IIM) patients…”
    Get full text
    Journal Article
  17. 17

    Statins and myositis: the role of anti-HMGCR antibodies by Selva-O'Callaghan, Albert, Alvarado-Cardenas, Marcelo, Marin, Ana, Pinal-Fernandez, Iago

    Published in Expert review of clinical immunology (02-12-2015)
    “…Muscle toxicity is a recognized adverse effect of statin use. Recently, a new myositis syndrome was described in association with antibodies directed against…”
    Get more information
    Journal Article
  18. 18

    Anti-HMGCR Specificity of HALIP: A Confirmatory Study by Selva-O'Callaghan, Albert, Martinez-Martinez, Laura, Mariscal, Anaís, Alvarado-Cardenas, Marcelo, Martinez, Maria Angeles, Baucells, Andrés, Juárez-Rubio, Cándido

    Published in Journal of immunology research (2020)
    “…A distinctive new indirect immunofluorescence pattern in liver tissue has been associated with anti-HMGCR autoantibodies. It is known as HALIP (HMGCR…”
    Get full text
    Journal Article
  19. 19

    Effect of mycophenolate sodium in scleroderma-related interstitial lung disease by Simeón-Aznar, Carmen Pilar, Fonollosa-Plá, Vicent, Tolosa-Vilella, Carles, Selva-O’Callaghan, Albert, Solans-Laqué, Roser, Vilardell-Tarrés, Miquel

    Published in Clinical rheumatology (01-11-2011)
    “…This study aims to determine the effectiveness of mycophenolate sodium (MS) in patients with scleroderma (SSc)-related interstitial lung disease (ILD). In a…”
    Get full text
    Journal Article
  20. 20

    Classification and management of adult inflammatory myopathies by Selva-O'Callaghan, Albert, Pinal-Fernandez, Iago, Trallero-Araguás, Ernesto, Milisenda, José César, Grau-Junyent, Josep Maria, Mammen, Andrew L

    Published in Lancet neurology (01-09-2018)
    “…Inflammatory myopathies, collectively known as myositis, are heterogeneous disorders characterised by muscle inflammation, and frequently accompanied by…”
    Get full text
    Journal Article